Results 251 to 260 of about 982,599 (302)
Some of the next articles are maybe not open access.

Plasmid DNA Vaccines

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, 2001
Genes that code for the production of protein antigens have been cloned and recombined with plasmids. Gene-plasmid constructs have been amplified in a bacterial host, purified and administered to a mammalian host. The gene is expressed in the host and the antigen that is produced induces an immune response.
G, Mor, M, Eliza
openaire   +4 more sources

Dephosphorylation of Plasmid DNA

Cold Spring Harbor Protocols, 2020
This protocol presents a method to remove 5′-phosphate residues from protruding or blunt termini of linearized plasmids. This suppresses the recircularization of plasmid DNA during subsequent ligation procedures.
Michael R, Green, Joseph, Sambrook
openaire   +2 more sources

Plasmid DNA purification

The Journal of Gene Medicine, 2004
The demand for efficient production methods of plasmid DNA (pDNA) has increased vastly in response to rapid advances in the use of pDNA in gene therapy and in vaccines since the advantageous safety concerns associated with non-viral over viral vectors.A prerequisite for the success of plasmid-based therapies is the development of cost-effective and ...
Joachim, Stadler   +2 more
openaire   +2 more sources

Chromatography of plasmid DNA

Journal of Chromatography A, 2005
Liquid chromatography plays a central role in process-scale manufacturing of therapeutic plasmid DNA (pDNA) for gene therapy and DNA vaccination. Apart from its use as a preparative purification step, it is also very useful as an analytical tool to monitor and control pDNA quality during processing and in final formulations.
M M, Diogo   +2 more
openaire   +2 more sources

Plasmid DNA Manufacturing Technology

Recent Patents on Biotechnology, 2007
Today, plasmid DNA is becoming increasingly important as the next generation of biotechnology products (gene medicines and DNA vaccines) make their way into clinical trials, and eventually into the pharmaceutical marketplace. This review summarizes recent patents and patent applications relating to plasmid manufacturing, in the context of a ...
Aaron E, Carnes, James A, Williams
openaire   +2 more sources

Quick Transformation with Plasmid DNA

Cold Spring Harbor Protocols, 2022
Genomic engineering of Escherichia coli and Salmonella often requires introducing plasmids into strains obtained during the intermediate stages of the process. Such strains are typically transformed only once, making the preparation of large batches of competent cells for storage purposes unnecessary.
Nara Figueroa-Bossi   +2 more
openaire   +2 more sources

Preparing Plasmid DNA from Bacteria

Cold Spring Harbor Protocols, 2022
The most common method for isolating plasmid DNA is derived from an alkaline lysis procedure. The procedure exploits the differential partitioning of plasmid and chromosomal DNA when denatured by alkali and subsequently renatured by neutralization of the medium.
Nara Figueroa-Bossi   +2 more
openaire   +2 more sources

YEAST DNA PLASMIDS

Annual Review of Microbiology, 1983
The study of yeast DNA plasmids has been initiated with the discovery of the 2-micron DNA in Saccharomyces cerevisiae. This multiple copy plasmid, organized into chromatin structure in vivo, probably exists in the nucleus and provides a good system to obtain information on eukaryotic DNA replication.
openaire   +2 more sources

Phytoplasma Plasmid DNA Extraction

2012
Phytoplasma plasmids have generally been detected from DNA extracted from plants and insects using methods designed for the purification of total phytoplasma DNA. Methods include extraction from tissues that are high in phytoplasma titre, such as the phloem of plants, with the use of CsCl-bisbenzimide gradients that exploit the low G+C content of ...
Mark T, Andersen, Lia W, Liefting
openaire   +2 more sources

Plasmid DNA vaccination

Microbes and Infection, 2005
Plasmid DNA vaccination against tuberculosis is a very powerful and easy method for the induction of strong humoral responses, CD4+ mediated secretion of Th1 cytokines and CD8+ mediated CTL activity in mice. Tuberculosis DNA vaccines have not been assessed so far in humans, and clinical trials with DNA in general have been somewhat disappointing ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy